SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011213
Filing Date
2021-08-11
Accepted
2021-08-11 06:30:54
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rphm-20210630x10q.htm   iXBRL 10-Q 1812266
2 EX-31.1 rphm-20210630xex31d1.htm EX-31.1 12160
3 EX-31.2 rphm-20210630xex31d2.htm EX-31.2 12240
4 EX-32.1 rphm-20210630xex32d1.htm EX-32.1 7276
5 EX-32.2 rphm-20210630xex32d2.htm EX-32.2 6170
6 GRAPHIC rphm-20210630x10q004.jpg GRAPHIC 11204
  Complete submission text file 0001558370-21-011213.txt   5760317

Data Files

Seq Description Document Type Size
7 EX-101.SCH rphm-20210630.xsd EX-101.SCH 39283
8 EX-101.CAL rphm-20210630_cal.xml EX-101.CAL 30444
9 EX-101.DEF rphm-20210630_def.xml EX-101.DEF 155216
10 EX-101.LAB rphm-20210630_lab.xml EX-101.LAB 363833
11 EX-101.PRE rphm-20210630_pre.xml EX-101.PRE 275152
12 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20210630x10q_htm.xml XML 759898
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40315 | Film No.: 211161897
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences